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ABSTRACT
Staufen1 is a component of transported ribonu-
cleoprotein complexes. Genetic work in Drosophila
has suggested that Staufen plays a role in the
de-repression of translation of oskar mRNA follow-
ing localization. To determine whether Staufen1 can
play a similar role in mammals, we studied transla-
tion of transcripts in the presence or in the absence
of Staufen1. Translationally repressed mRNAs were
generated by fusing the structured human immuno-
deficiency virus type 1 trans-activating response
(TAR) element to the 50 end of a reporter transcript.
In rabbit reticulocyte lysates and in mammalian
cultured cells, the addition of Staufen1 resulted in
theup-regulationofreporteractivitywhentranslation
was driven by the TAR-bearing RNA. In contrast,
Staufen1 had no effect on translation of efficiently
translated mRNAs lacking an apparent structured
50 end, suggesting that Staufen1-binding to the 50
end is required for enhanced translation. Con-
sistently, Staufen1 RNA-binding activity is necessary
for this translational effect. In addition, similar
up-regulation of translation was observed when
Staufen1 was tethered to the 50 end of mRNAs via
other structured RNAs, the highest level of transla-
tional increase being obtained with the bona fide
Staufen1-binding site of the Arf1 transcript. The
expression of Staufen1 promoted polysomal loading
of TAR-luciferase transcripts resulting in enhanced
translation. Our results support a model in which
the expression of Staufen1 and its interaction with
the 50 end of RNA and ribosomes facilitate translation
initiation.
INTRODUCTION
Intracellular localization of mRNA is a universal phenomenon
that is conserved in plants and animals (1–3). It has been
shown to be important for cell motility (4), asymmetric cell
division (5), axis formation during development (6), synaptic
plasticity (7) and long-term potentiation (8). One general con-
cept that emerges from studies on mRNA localization is the
link that exists between localization and translation (3,9).
mRNA is translationally silent during transport, but its trans-
lation becomes de-repressed following transport, resulting in
localized protein synthesis. While several mechanisms to
achieve translational repression during transport have been
described, these largely involve the association of a repressor
to the 30-untranslated region (30-UTR) (10–14) or the presence
of an inhibitory RNA structure in the 50-UTR to block trans-
lational initiation (15,16).
In contrast, there are few details known about the mecha-
nism that controls the de-repression of translation following
mRNA transport. Work in Drosophila has suggested that
RNA-binding proteins can play a role here. For example,
Staufen is a double-stranded RNA (dsRNA)-binding protein
(17) that is required for the de-repression of oskar mRNA
translation in oocytes (10,18). The mechanism underlying
this function of Staufen is not known. In mammals, Staufen1
(Stau1
55) (19,20) is a component of RNA transport granules
and ribosome-free RNA particles (21,22). It is believed to play
important role(s) in the transport of RNA to dendrites (23–25)
and because it is also associated with polysomes (19,20,26–
28), it is likely to be involved in the translation of mRNAs.
To address the role of Staufen1 in translation, we used
the well-studied model of translational repression involving
the human immunodeﬁciency virus type 1 (HIV-1) trans-
activating response region (TAR). The TAR RNA sequence
is present at the 50 end of all HIV-1 transcripts and forms
a stable secondary RNA structure consisting of a stem–loop
with a bulge. It inhibits translation by making the RNA cap
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and more generally by activating the interferon response
pathway (15,30,31). In addition to the viral protein Tat (32),
many cellular factors, including the dsRNA-dependent kinase
(PKR) (33), the TAR-RNA-binding protein (TRBP) (34), the
RNA helicase A (RHA) (35) and the La autoantigen (36), have
been shown to interact with the RNA TAR structure. Some of
these proteins also regulate translation of TAR-containing
transcripts. PKR becomes activated when bound to TAR
(15,31). Activated PKR phosphorylates the translation initia-
tion factor 2a (eIF-2a) thus causing general inhibition of
translation (37–40). In contrast, TRBP which was identiﬁed
in a large-scale screen for cellular TAR interacting proteins
(34) partially relieves the TAR-induced inhibition of transla-
tion through a PKR-independent pathway (41). Similarly,
the La autoantigen stimulates translation of TAR-bearing
transcripts through its ATP-dependent helicase activity that
disrupts the TAR secondary structure (42,43).
In this report, we studied the role of Stau1
55 in translation in
both rabbit reticulocyte lysates (RRLs) and in human embry-
onic kidney (HEK)293T cells. To generate translation-
ally repressed transcripts, we fused dsRNA structures to the
50 end of reporter transcripts. Our studies show that Stau1
55
stimulates translation of structure-repressed mRNA in a
mechanism that requires Stau1
55-binding to the 50 end of
transcripts. Therefore, Staufen1 expression and binding are
important factors to regulate translation of some RNAs and
to contribute to the de-repression of translation following
mRNA localization.
MATERIALS AND METHODS
Antibodies and reagents
Mouse polyclonal anti-ribosomal L7/SPA protein antibodies
were obtained from Novus Biologicals (Littleton, CO), mouse
monoclonal anti-tubulin antibodies from ICN (Aurora, OH),
rabbit polyclonal anti-calnexin antibodies from Stressgen
Biotechnologies (Victoria, BC, Canada) and anti-mouse and
anti-rabbit polyclonal antibodies conjugated to horseradish
peroxidase from DakoCytomation (Mississauga, ON,
Canada). To generate Stau1
55 monoclonal antibodies, bacte-
rially expressed human GST-Stau1
55D2 was afﬁnity puriﬁed
on a glutathione Sepharose matrix (Amersham Biosciences
Corp, Piscataway, NJ) and eluted from the columnby cleavage
with thrombin. Mice were injected with 10 mg of antigen per
injection. Following serum conversion, spleens of positive
mice were isolated and monoclonal antibodies (11C6) were
prepared as described previously (44). G418 and 2-
aminopurine (2-AP) were purchased from Sigma (Oakville,
ON, Canada).
cDNA construction
Plasmids coding for Stau1
55D2-his6 (formerly named
HFBDQ-his6), NEP-his6, Stau1
55-HA3 (20) and Stau1
55F-
HA3 (26) were described previously. Plasmids containing
mutations in TAR were generated from the p48 (pCD, pEF,
pGH and pIJ) or p49 (pAB) plasmids (generous gifts from
K. T. Jeang, NIH/NIAID Bethesda, MD) by ligation of
double-stranded synthetic oligonucleotides (Table 1) within
the TAR sequence. The p48 and p49 plasmids were ﬁrst
digested with SmaI/EcoRI and AvaI/EcoRI, respectively, trea-
ted with the Klenow fragment to blunt ends and ligated to
remove the SacI restriction site in the multi-cloning site. Then,
plasmids were digested with Sac1 in the TAR sequence and
either BamH1 (pAB), BglII (pCD) or HindIII (pEF, pGH and
pIJ), puriﬁed and ligated with oligonucleotides. La-his6 plas-
mid was obtained by subcloning the BamHI/HindIII fragment
of La-pBS SK (a generous gift from K. T. Jeang) in frame with
the his6 tag in the pQE31 expressing plasmid (Qiagen,
Mississauga, ON, Canada). pcDNA3 RSV-Rluc plasmid
was constructed by subcloning the HindIII–XbaI PCR frag-
ment from pRluc-N1(h) (PerkinElmer Biosignal Inc, Mont-
real, QC, Canada) into the XbaI–HindIII sites of pcDNA3
RSV plasmid (45). The PCR was carried out with 2 U of
Vent DNA polymerase (New England Biolabs, Pickering,
ON, Canada) and the sense 50-CTCACGCGTCTGCAG-30
and antisense 50-GGCTGATTATGCTCTAGATCG-30 pri-
mers. The pcDNA3 RSV-TAR-Rluc plasmid was constructed
by subcloning the TAR-containing HindIII fragment of
pSp6TAR-CAT plasmid (a generous gift from E. Cohen, Uni-
versity of Montreal) into the HindIII site of pcDNA3 RSV-
Rluc. The sh1 and sh2 plasmids were obtained by the PCR
SHAGgingstrategy (46).TworoundsofPCRwerecarriedout.
A ﬁrst PCR was carried out on the pGEM-U6 plasmid (a
generous gift from G. Ferbeyre, University of Montreal) with
50 pmol of U6 sense 50-GATTTAGGTGACACTATAG-30
and sh1 50-AAAAAAATAAGGATCAACAGGCTTATAC-
ATCGGCTCAAGCTTCAACCAATGTATAAGCCTGTTG-
ACCCTTACGGTGTTTCGTCCTTTCCACAA-30 or sh2
50-AAAAAAACACCTCCCACACACAGACATCGGCCCA-
TCAAGCTTCACGGACCAATGTCTGTGTGTGGGAGGT-
GCGGTGTTTCGTCCTTTCCACAA-30 antisense primers.
PCR was carried out with 100 ng pGEM-U6 template, 5 U
AmpliTaq DNA polymerase (Applied Biosystems), 4%
dimethyl sulfoxide, 0.2 mM dNTPs and 1.5 mM MgCl2
(95 C for 3 min, 30 cycles at 95 C for 30 s, 55 C for 30 s,
72 C for 1 min, followed by a 10 min incubation at 72 C).
PCR products were puriﬁed on low-melt agarose gel, and
ethanol precipitated. They were then cloned as followed:
using the ﬁrst PCR SHAG products as template, a second
PCR ampliﬁcation was carried out with 0.2 mMo fU 6
sense 50-ACAGAATTCGATTTAGGTGACACTATAG-30
(underlined: the EcoRI restriction site) and sh1 antisense 50-
ACACTCGAGAAAAAAATAAGGATCAACAGGCTTA-30
(underlined: the XhoI restriction site) or sh2 antisense
Table 1. Oligonucleotides used to mutate the TAR sequence
TAR
mutant
Oligonucleotide sequence
pAB 50-CTCTGGCTAACTAGGGAACCCG-30
30-TCGAGAGACCGATTGATCCCTTGGGCCTAG-50
pCD 50-GATCTGAGCCCAAAAGCT-30
30-ACTCGGGTTT-50
pEF 50-AGCTTGGGTCTCTCTGGTTAGACCAGATCTGTCGCTGGGAGCT-30
30-ACCCAGAGAGACCAATCTGGTCTAGACAGCGACCC-50
pGH 50-AGCTTGGGTCTCTCTGGTTAGACCAGA___GAGCCTGGGAGCT-30
30-ACCCAGAGAGACCAATCTGGTCT___CTCGGACCC-50
pIJ 50-AGCTTGGGTCTCTCTGGTTAGACCAGAAAGGAGCCTGGGAGCT-30
30-ACCCAGAGAGACCAATCTGGTCTTTCCTCGGACCC-50
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CACAGAC-30 (underlined: the XhoI restriction site) at
95 C for 1 min, 58 C for 1 min, 72 C for 1 min for 35 cycles.
The resulting PCR products were digested with EcoRI/XhoI
and subcloned in pBluescript KS plasmid (Stratagene).
The Stau1
55Dsh1-HA3 plasmid was PCR ampliﬁed from
Stau1
55-HA3 plasmid with the all-around technique using
the sense 50-CTTACTCTCGGACGCAGTCCACCTA-30 and
antisense 50-TAGGTGGACTGCGTCCGAGAGTAAG-30
oligonucleotide primers. Similarly, Stau1
55KK-HA3 was PCR
ampliﬁed from Stau1
55-HA3 plasmid using the sense
50-AGCGCGGCGATTTCAAAGAAAAATGCC-30 and anti-
sense 50-AATCGCCGCGCTTTTCCCTTCACC-30 primers.
The MS2bs-Rluc plasmid was obtained by subcloning the
KpnI digestion fragment of the pSL-MS2 plasmid (a kind gift
from P. Chartrand, University of Montreal) in the KpnI site
of the pcDNA3 RSV-Rluc plasmid. The pcDNA3 RSV
SBS-Rluc plasmid was obtained by PCR ampliﬁcation of the
Staufen1-binding site (SBS) from the pSport-Arf1 plasmid
using the sense 50-CAGCTCCGGAACCAGAAGTGAAC-30
and antisense 50-AGGACCCGGGAACACAGCGACTCCT-
GGAGG-30 (underlined: the XmaI restriction site) at 95 C
for 1 min, 57 C for 45 s, 72 C for 45 s for 35 cycles. PCR
products were kinased and digested with XmaI restriction
enzyme, puriﬁed and subcloned in the EcoRV/XmaI sites
of pBluescript SK. pBluescript SK SBS plasmid was
digested by HindIII/BamHI and the digestion fragment was
subcloned in the HindIII/BamHI sites of the pcDNA3
RSV-Rluc plasmid.
Recombinant protein production and purification
Bacterially expressed Stau1
55D2-his6 and NEP-his6 were
induced for 3 h with 1 mM isopropyl-b-D-thiogalactopyra-
noside and puriﬁed as described previously (20). Aliquots
of puriﬁed proteins were stored at  80 C until use. Protein
concentration was determined by the BioRad dye reagent and
BSA as standard.
In vitro assays
The SpIII-10 CAT and pSp64TAR-CAT plasmids (generous
gift from E. Cohen, University of Montreal) were linearized
at the BamHI site, transcribed in vitro using the Sp6 RNA
polymerase and m7GpppG CAP analog and used for in vitro
translation in RRLs as described previously (42). One-ﬁfth
volume of CAT and one volume of TAR-CAT translation
products were either loaded on gel and detected by autoradio-
graphy or quantiﬁed by enzyme-linked immunosorbent assay
(ELISA) as indicated by the manufacturer (Roche Biochemi-
cals, Laval, QC, Canada). For the in vitro ribosome pull-down
assay, 250 ng of Stau1
55D2-his6, in the presence or in the
absenceof50ngofTAR-CATRNA,wereincubatedwithRRL
for 1 h. The reaction mixture was diluted to 300 ml with
ice-cold isotonic buffer (110 mM KOAc, 2 mM MgOAc,
10 mM HEPES–KOH, pH 7.3 and 2 mM DTT) and
centrifuged in a Beckman SW 50.1C rotor for 45 min at
100000 g at 4 C. The ribosome-enriched pellet was harvested
and analysed by SDS–PAGE. The helicase assay was per-
formed as described previously (43). Northwestern and ﬁlter
binding assays were carried as described previously (20). For
immunoprecipitation, transfected cells were lysed in 600 mlo f
lysis buffer (50 mM Tris–Cl, pH 7.5, 0.5% Triton X-100,
EDTA 15 mM and DTT 1 mM). Cells extracts were pre-
cleared with 60 ml of 50% v/v Protein A-Sepharose slurry
(Roche) for 1 h and then incubated with 3 ml of anti-HA ascite
ﬂuid (12CA5) at 4 C for 2 h and with 150 ml of 50% v/v
Protein A-Sepharose slurry at 4 C for 2 h.
RNA steady-state level
HEK293T cells were cultured in 12-well dishes and trans-
fected with 100 ng of pcDNA3 RSV-Rluc or pcDNA3
RSV-TAR-Rluc in the absence or in the presence of increasing
quantities of pcDNA3 RSV-Stau1
55-HA3 with FuGene6 trans-
fection reagent (Roche). Twenty-four hours post-transfection,
total RNA was extracted with Trizol reagent (Invitrogen Life
Science, Burlington, ON, Canada) and treated with DNase I
for 1 h at 37 C. Rluc, TAR-Rluc and GAPDH RNAs were
reverse transcribed at 42 C for 17 min using 1 mg of total
RNA,5pmol ofRluc (50-CAGCACTCTCTCCACGAAGC-30)
and GAPDH (50-CAAAAGTTGTCATGGATGACC-30)
antisense primers using the GENEAMP RNA PCR core kit
(Applied Biosystems, Foster City, CA). Rluc (50-GCAAGGT-
GTACGACCCCG-30) and GAPDH (50-CCTTCATTGACCT-
CAACTACAT-30)senseprimers(250ng)were added forPCR
ampliﬁcation (95 C for 2 min, followed by 17 cycles at 94 C
for 1 min, 54 C for 1 min and 72 C for 1 min). Resulting
products were resolved on a 1.25% agarose gel. Similarly,
50 ng of CAT or TAR-CAT RNAs were incubated with
RRL at 30 C for 0, 7.5, 15 or 30 min in the presence of
40 mg/ml of G418. RNA was extracted with Trizol reagent
and reverse transcribed using 5 pmol of CAT antisense primer
(50-CCACTCATCGCAGTACTGTTG-30). PCRs were carried
out at 95 C for 2 min, followed by 14 cycles at 94 C for 1 min,
52.5 C for 1 min and 72 C for 1 min using 250 ng of CAT
sense primer (50-CCTATAACCAGACCGTTCAGC-30) and
antisense primer (50-CCACTCATCGCAGTACTGTTG-30).
Resulting products were resolved on a 1.5% agarose gel.
Transfection and luciferase assays
HEK293T cells and PKR
 /  MEF (a generous gift from A.
Gatignol, McGill University) were cultured in DMEM (Invit-
rogen Life Science) supplemented with 10% Cosmic calf
serum (Hyclone, Logan, UT), 5 mg/ml of penicillin–
streptomycin and 2 mM L-Glutamine (Invitrogen Life
Science). To test the role of Stau1 in translation, cells were
transfected with FuGene6 (Roche Biochemicals) using 100 ng
of pcDNA3 RSV-Rluc or pcDNA3 RSV-TAR-Rluc and
increasing concentrations (0, 50, 100 and 500 ng) of plasmid
coding for Stau1
55-HA3 or its mutants. Total amount of trans-
fected DNA was adjusted to 600 ng with the pcDNA3 RSV
plasmid. Cells were harvested 24 h post-transfection in 100 ml
of lysis buffer (0.1 M Tris–Cl, pH 7.9, 0.5% NonidetP40 and
1mMDTT)for5minonice.Analiquotof25mloftheextracts
and 5 mM Coelenterazine H (Molecular Probes, Burlington,
ON, Canada) were used for Renilla reniformis luciferase
assays. Luminescence was quantiﬁed with a Fusion a-FP
(PerkinElmer-Canberra Packard BioScience) by measuring
emitted light at 475–480 nm. To knockdown the expression
of Stau1, HEK293T cells were transfected with Lipofectamine
2000 (Invitrogen Life Science) using 700 ng of the silencing
sh1 or the non-silencing sh2 plasmids. For translation assays,
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and plasmid DNA as described above. Knockdown
rescue was performed with 300 ng of plasmid coding for
Stau1
55Dsh1-HA3.
Cell fractionation on sucrose gradients
Polyribosome proﬁle was analysed as described previously
(26). Brieﬂy, transfected HEK293T cells were incubated
for 20 min with cycloheximide (100 mg/ml), washed in cold
phosphate-buffered saline and isotonic buffer and lysed
in hypotonic buffer supplemented with cycloheximide
(100 mg/ml). For the run-off experiments, cells were incubated
for 30 min with sodium azide (25 mM) instead of cyclohex-
imide. Cytoplasmic extracts (corresponding to  20 OD260)
were centrifuged on a continuous 10–40% or 15–45%
sucrose gradient containing 100 mM KCl, 10 mM KOAc,
2 mM MgOAc, 1 mM DTT and 5 mM HEPES–KOH,
pH 7.3, with or without cycloheximide (100 mg/ml) in a
SW41 rotor (Beckman) at 160000 g for 150 min at 4 C.
Fourteen fractions of  800 ml were recovered and the ribo-
somal proﬁle was monitored at OD254 with a gradient frac-
tionator (ISCO, Lincoln, USA). Aliquots containing 25 mlo f
each fraction were analysed by SDS–PAGE and western
blotting. For RNA analysis, total RNA was extracted from
a 250 ml aliquot of each fraction by adding an equal volume
of denaturing buffer [7 M urea, 1% (w/v) SDS, 350 mM NaCl,
10 mM EDTA and 10 mM Tris–HCl, pH 7.5] followed by
phenol–chloroform extraction and ethanol precipitation. RNA
samples were incubated for 5 min at 65 C in RNA denaturing
solution [66% (v/v) formamide, 8% (w/v) formaldehyde, 1·
MOPS electrophoresis buffer] and slot-blotted onto nylon
membrane using a HybriSlot apparatus (Gibco BRL).
Membranes were hybridized with a random-prime
32P-
labelled Rluc DNA fragment, exposed overnight and revealed
by autoradiography.
RESULTS
Stau1
55 stimulates translation of inefficiently
translated transcripts in RRL
To determine whether Stau1
55 regulates translation, we ﬁrst
set-up an in vitro translation assay using RRLs. Translation
efﬁciencies of capped chloramphenicol acetyl transferase
(CAT)RNAandTAR-CATRNA(Figure1A)were compared.
Similar to previous data (29,47), the translation of a transcript
that contains TAR at the 50 end is repressed in RRL
(Figure 1B). Then, bacterially expressed and puriﬁed
Stau1
55D2-his6 or NEP-his6 as control (Figure 1C) were tested
for their capacity to associate with ribosomes as reported in
culturedcells(26).Stau1
55D2-his6wasused instead ofthe full-
length Stau1
55 because this protein is more soluble than full-
length. RRLs were incubated in the presence or in the absence
of 250 ng of recombinant Stau1
55D2-his6 and extracts were
centrifuged at 100000 g for 45 min to pellet ribosomes.
Ribosomal pellets were separated by SDS–PAGE and
analysed by western blotting using anti-Stau1 and anti-L7
ribosomal protein antibodies. After centrifugation, recombi-
nant Stau1
55D2-his6 was found in the pellet with endogenous
Stau1 and ribosomes (Figure 1D). The addition of TAR-CAT
RNA had no effect on Staufen quantities in the ribosomal
pellet, consistent with our previous demonstration that
Stau1 interaction with ribosomes is RNA independent (26).
When centrifuged in the absence of RRL, Stau1
55D2-his6 was
not detected in the pellet (Figure 1D). These results show that
puriﬁed Stau1
55D2-his6 associates with ribosomes in RRL in
the presence or in the absence of added RNAs and that it is not
over-represented as compared with endogenous Stau1 in
this assay.
RRLs were then incubated with CAT or TAR-CAT tran-
scripts (4 mg/ml). At this RNA concentration, the translation
capacity of RRL was not saturated and a 17-fold repression of
translation of the TAR-CAT RNA was observed as compared
with translation of CAT RNA (Figure 1B). Increasing con-
centrations of recombinant Stau1
55D2-his6 or NEP-his6 were
tested for their ability to stimulate translation. Stau1
55D2-his6
enhanced translation of the repressed TAR-CAT RNA in a
dose-dependent manner reaching 15-fold (Figure 1E). This
effect was speciﬁc since NEP-his6 had no effect on TAR-
CAT RNA translation. In contrast, Stau1
55D2-his6 did not
markedly affect translation efﬁciency of CAT RNA, showing
a 2-fold increase (Figure 1E). A sensitive CAT ELISA was
also used to quantify the in vitro synthesis of CAT. These
assays demonstrated that Stau1
55D2-his6 increases translation
of TAR-repressed transcripts by 10-fold and that of normally
translated mRNAs by only 2-fold (Figure 1F).
Stau1
55 stimulates translation of TAR-containing
transcripts in mammalian cells
The effects of Staufen on translation efﬁciency were
then measured in mammalian HEK293T cells. Cells were
transfected with plasmids that expressed either Renilla reni-
formis luciferase (Rluc) or TAR-Rluc transcripts. The TAR-
mediated translational repression was also observed in this
context showing a 2-fold decrease in luciferase activity as
compared with that of the Rluc transcript (Figure 2A).
HEK293T cells were then co-transfected with increasing
amounts of Stau1
55-HA3 expressor construct (Figure 2B)
and either Rluc or TAR-Rluc plasmids. As shown in
Figure 2A, Stau1
55-HA3 stimulated translation of TAR-Rluc
RNA 2-fold when compared with TAR-Rluc RNA translation
in the absence of transfected Stau1
55-HA3. In contrast, it had
no effect on translation of Rluc transcript as indicated by a
stable luciferase activity. Therefore, Stau1
55-HA3 rescued the
inhibition imposed by the TAR sequence on the translation of
TAR-Rluc transcripts. Importantly, the optimal amount of
plasmid (100 ng) that enhances translation of TAR-Rluc
mRNA results in Stau1
55-HA3 expression levels that are quan-
titatively close to that of endogenous Stau1
55, as shown in
Figure 2B.
In order to examine the effect of Staufen on translation, we
then used RNAi to knockdown Staufen expression on
HEK293T cells expressing the Rluc transcripts as above.
Short hairpin (sh) RNA-expressing plasmids (Figure 2C)
were used to knockdown endogenous expression of Stau1. sh1
was shown to result in a 92% decrease in Stau1 protein
expression (Figure 2D). Therefore, sh1- (silencing) or control
sh2- (non-silencing) expressing plasmids were co-transfected
with plasmids that expressed either Rluc or TAR-Rluc. Sh1
caused a signiﬁcant 30% decrease (P < 0.05) in luciferase
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(Figure 2E). In contrast, sh1 had no effect on luciferase activ-
ity when the Rluc transcript was expressed. sh2 did not modu-
late luciferase activity when either RNA was expressed
(Figure 2E). In an attempt to demonstrate that the effect of
Staufen on translation was indeed due to Staufen, we per-
formed an experiment in which sh1 was used to knock-
down expression of endogenous Staufen, but co-expresssed
Staufen in trans using a vector that does not have the
sh1 target sequence (Stau1
55Dsh1-HA3, M. Luo and
L. DesGroseillers, unpublished data) (Figure 2C and D).
The results showed that the effects were speciﬁc to Staufen
expression (Figure 2E). Taken together, the results obtained
from three different approaches show that Stau1
55 modulates
the expression of translationally repressed TAR-containing
transcripts but has no effect on efﬁciently translated mRNAs.
Figure 1. Stau1
55 increases translation of TAR-bearing RNA in RRL. (A) Schematic representation of transcripts. RNAs coding for the CAT reporter protein are
shown with or without a double-stranded TAR RNA structure at the 50 end. (B) Translation of in vitro synthesized CAT and TAR-CAT transcripts in RRL. TAR
structure at the 50 end of the transcript represses translation. Vertical arrow, RNA concentration (4 mg/ml) subsequently used in the in vitro translation assays. (C)
Bacterially expressed NEP-his6 (NEP) and Stau1
55D2-his6 (Stau) were purified on Ni-NTA columns, analysed by SDS–PAGE and Coomassie blue staining. Wild-
type Stau1
55 and the truncated Stau1
55D2-his6 are schematically represented. Black boxes, full-length double-stranded RNA-binding domains (dsRBD) 3 and 4;
whiteboxes,halfsizedsRBD2and5;hatchedbox,thetubulinbindingdomain(TBD).(D)BacteriallyexpressedandpurifiedStau1
55D2-his6wasadded(+)toRRLin
thepresence(+)orintheabsence( )ofTAR-CATRNA.ExtractswerecentrifugedandproteinsinthepelletwereanalysedbySDS–PAGE.Proteinswererevealed
withanti-Stau1andanti-ribosomalproteinL7antibodies.EndogenousStau1 in RRLis visibleat 55kDa.I, inputis 250 ng protein.(E)A representative experiment
showing that Stau1
55D2-his6 increases translation of TAR-CAT RNA in RRL. CAT or TAR-CAT RNAs (4 mg/ml) were incubated in RRL with increasing
concentrations of bacterially purified Stau1
55D2-his6 or NEP-his6, in the presence of [
35S]methionine. Resulting proteins were analysed by SDS–PAGE and
autoradiography. Note that one-fifth volume of CAT and one volume of TAR-CAT translation products were loaded on gel. (F) In this experiment, in vitro
synthesized CAT was measured using ELISA (n ¼ 4). Statistical analyses of TAR-CAT (open bars) and CAT (black bars) RNA translation in relation to the
concentration of Stau1
55D2-his6. In the absence of Stau1
55D2-his6, a 17-fold repression of translation of the TAR-CAT RNA was observed as compared with
translation of CAT RNA. Results are expressed as fold induction in CAT activity versus the concentration of the Stau1
55D2-his6 coding plasmid. To facilitate
comparison, fold induction of the CAT activity in the absence of Stau1
55D2-his6 was defined as 1.
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55-dependent translational stimulation is
independent of PKR activity
The ability of Stau1
55 to modulate the expression of TAR-
repressed transcripts was distinguished from a competition
with PKR for binding the dsRNA TAR structure by in vitro
translation assay in the presence of 2-AP, a Ser/Thr kinase
inhibitor (48). As shown before (49), 2-AP treatment of
RRL slightly increased translation of the TAR-CAT transcript
2-fold likely by relieving a partial translational repression
imposed by PKR. However, increasing concentrations
of Stau1
55D2-his6 still stimulated translation of the TAR-
containing transcript 8-fold. This shows that 2-AP did not
prevent Stau1
55-dependent activation of translation
(Figure 3A and B). In contrast, 2-AP prevented the 2-fold
induction observed with Stau1
55D2-his6 on CAT RNA trans-
lation (Figure 3A and B), showing that, in this case, the
increase in translation that is mediated by Staufen may be
PKR dependent.
To conﬁrm these results, we tested the effects of Stau1
55 in
PKR-deﬁcient cells (PKR
 / ) (50). PKR
 /  cells were co-
transfected with plasmids coding for Stau1
55-HA3 and either
Rluc or TAR-Rluc. As observed in HEK293T cells, Stau1
55-
HA3 increased translation of TAR-Rluc mRNA by 2-fold,
whereas it has no effect on Rluc transcripts (Figure 3C).
Figure 2. Stau1
55-HA3 increases translation of TAR-Rluc transcripts in HEK293T cells. (A) HEK293T cells were co-transfected with plasmids expressing either
RlucorTAR-RluctranscriptsanddifferentconcentrationsofaplasmidcodingforStau1
55-HA3.Resultingluciferaseactivitywasquantified24hpost-transfection.In
theabsenceofStau1
55-HA3,a2-foldrepressionoftranslationoftheTAR-RlucRNAwasobservedascomparedwithtranslationofRlucRNA.Resultsareexpressed
asfoldinductioninluciferaseactivityversustheconcentrationoftheStau1
55-HA3codingplasmid.Tofacilitatecomparison,foldinductionoftheluciferaseactivity
intheabsenceofStau1
55-HA3wasdefinedas1.Blackbars,TAR-RlucRNA;hatchedbars,RlucRNA.**P < 0.01,n ¼ 3.(B)HEK293Tcellsweretransfectedwith
different concentrationsof a plasmid coding forStau1
55-HA3. Western blot analyses showed that, formost dilutions,Stau1
55-HA3 (60 kDa) is not overexpressed as
comparedwithendogenousStau1
55(55kDa).(C)SchematicrepresentationofStau1
55Dsh1-HA3andpositionofthesh1andsh2RNAs.Symbolsaredescribedinthe
legendofFigure1.(D)HEK293Tcellsweretransfectedwithplasmidsexpressingsh1orshsh2RNAs(leftpanel)orco-transfectedwithplasmidsexpressingsh1RNA
andStau1
55Dsh1-HA3(rightpanel).ProteinswereanalysedbySDS–PAGEandwesternblottingusinganti-Stau1andanti-calnexin(Cnx)antibodies.Thepercentage
ofdown-regulationofendogenousStau1
55isindicatedatthebottomofthefigure.PositionofendogenousStau1
63andofStau1
55isindicatedbytwoandoneasterisk,
respectively. (E) HEK293T cells were transfected as described in (D) in the presence of either TAR-Rluc or Rluc expressors. Resulting luciferase activity was
analysed as described in (B) (n ¼ 3). Expression of sh1 decreased luciferase activity that is rescued by expression of Stau1
55Dsh1-HA3.* P < 0.05.
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55-stimulating
effect on TAR-bearing RNA translation is achieved through
a PKR-independent pathway.
Stau1
55 binds to the TAR RNA structure
We next determined whether Stau1
55 binds the TAR RNA
structure in vitro since it is the only difference between the
Rluc and TAR-Rluc transcripts. Filter binding and Northwest-
ern assays (20) were used to examine this. These analyses have
allowed us to show that Stau1
55D2-his6 binds the TAR-RNA
structure with high afﬁnity with a Kd of 3.5 nM (Figure 4A).
Several mutants that disrupt speciﬁc regions of the TAR struc-
ture (Figure 4B) (34) were tested to map the Stau1
55D2-his6
binding site. Although mutations in the lower stem, in the
bulge or in the loop did not abolish binding of Stau1
55D2-
his6, mutations in the upper stem between the bulge and the
loop were critical (Figure 4A and C). As control, NEP-his6 did
not bind TAR RNA (data not shown). Altogether, these results
support a model in which Stau1
55D2-his6 binds to the TAR
RNA structure and this may be important for the observed
translational enhancement of RNAs that possess structured
50 regions.
Figure 3. Stau1
55-mediated increase of TAR-bearing RNA translation is independent of PKR. (A) In vitro protein synthesis in RRL was performed as described in
Figure1,exceptthatPKRwasinhibitedbyadditionoftheser/thrkinaseinhibitor2-AP.ThesamevolumeofCATandTAR-CATtranslationproductswasloadedon
gel. (B) Statistical analyses of TAR-CAT (left panel) and CAT (right panel) RNA translation in relation to the concentrationof Stau1
55D2-his6. In vitro synthesized
CAT was measured by ELISA (n ¼ 4). Black bars, 2-AP; open bars, controls. (C) PKR
 /  MEF cells were co-transfected with plasmids expressing either Rluc or
TAR-RluctranscriptsanddifferentconcentrationsofaplasmidcodingforStau1
55-HA3.ResultingluciferaseactivitywasmeasuredasdescribedinFigure2A.Inthe
absenceofStau1
55-HA3,a2-foldrepressionoftranslationoftheTAR-RlucRNAwasobservedascomparedwithtranslationofRlucRNA.Tofacilitatecomparison,
fold induction of the luciferase activity in the absence of Stau1
55-HA3 was defined as 1. Black bars, TAR-Rluc RNA; hatched bars, Rluc RNA. *P < 0.05, n ¼ 3.
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55 RNA-binding activity is required for
TAR-induced translational activation
Since Stau1
55 binds the TAR RNA structure at the 50 end of
the TAR-Rluc transcript, we then tested whether Stau1
55 bind-
ing to RNA is required for the observed up-regulation of
TAR-Rluc translation. Two mutants, Stau1
55F-HA3 (26) or
Stau1
55KK-HA3 (C. Martel and L. DesGroseillers, manuscript
submitted) (Figure 5A), were ﬁrst tested for their capacity to
bind the TAR RNA structure in vitro. Northwestern assays
using immunoprecipitated proteins isolated from HEK293T
cells showed that, in contrast to Stau1
55-HA3, both mutants
were impaired in their RNA-binding activity (Figure 5B).
Then, HEK293T cells were co-transfected with plasmids cod-
ing for either Stau1
55F-HA3 or Stau1
55KK-HA3 and with either
TAR-Rluc or Rluc vectors. Western blot analysis showed that
the levels of expression of the mutated proteins were quite
similar to that of Stau1
55-HA3 (Figure 5C). However, these
two mutants failed to stimulate the activity of either reporter
(Figure 5D). In the same experiment, Stau1
55-HA3 stimulated
translation of TAR-luciferase RNA 2-fold. These results sug-
gest that Stau1
55 binding to RNA is critical for enhanced
translation of TAR-containing transcripts.
The effects of Stau1
55 are at the level of translation
Three non-exclusive mechanisms may explain how Stau1
55
modulates translation of TAR-bearing transcripts: (i) increase
in stability of TAR-containing RNA, (ii) unwinding activity of
Stau1 on the TAR structure and/or (iii) direct binding to ribo-
somes or to translation factors and modulation oftheir activity.
To distinguish between an effect on TAR-bearing mRNA
itself and an effect on the translational machinery, we assessed
the ability of Stau1
55 to act at the level of RNA metabolism.
To address this possibility, TAR-CAT and CAT mRNAs
were incubated in RRL in the presence or in the absence of
Stau1
55D2-his6. An inhibitor of translation (G418) was added
to prevent mRNA association/protection with translating
Figure 4. Stau1
55D2-his6 binds the TAR-RNA structure in vitro. (A) Filter binding assays using bacterially expressed and column-purified Stau1
55D2-his6 and
[
32P]labelled TAR or bicoid 30-UTR RNA (left panel). Open squares, TAR RNA; black triangles, bicoid 30-UTR RNA. Similar experiments were performed with
[
32P]labelledTARmutants,allowingtocalculateKd(rightpanel).(B)SchematicrepresentationofdifferentmutantsalreadyusedtomapTAR-bindingproteins(34).
Position and nature of substituted nucleotides are indicated. (C) Northwestern assays using bacterially expressed and column-purified Stau1
55D2-his6 and
[
32P]labelled TAR and TAR mutants. The arrow indicates the position of Stau1
55D2-his6. The upper band likely represents dimers.
4804 Nucleic Acids Research, 2005, Vol. 33, No. 15ribosomes. Aliquots were taken at different time points and
RT–PCR ampliﬁcations were carried out using primers in the
CAT sequence. The presence of Stau1
55D2-his6, or that of
BSA as control, did not affect TAR-CAT (Figure 6A) or
CAT (data not shown) mRNA stability, indicating that the
RNA is as stable as in control conditions.
Similarly, we tested whether the steady-state levels of TAR-
Rluc and Rluc mRNAs in HEK293T cells varied with over-
expression of Stau1
55-HA3. TAR-Rluc or Rluc expressing
plasmids were co-transfected with increasing concentrations
of Stau1
55-HA3 cDNAs. Twenty-four hours post-transfection,
total RNA was extracted and semi-quantitative RT–PCR
assays were performed using primers in the Rluc sequence.
mRNA levels were normalized to endogenous gapdh mRNA.
Expression of Stau1
55-HA3 did not affect the steady-state lev-
els of TAR-Rluc and Rluc mRNAs (Figure 6B). Luciferase
assays performed on the same cell extracts showed the
expected increase in translation of TAR-Rluc RNA (data
not shown).
Stau1
55 could potentially unwind the double-stranded
TAR-RNA structure upon binding and facilitate translation.
To test this possibility, recombinant Stau1
55D2-his6 or the
RNA-binding protein La-his6 (43), used as a positive control
(Figure 6C, left panel), were incubated in the presence of
[
32P]labelled dsRNA and different combinations of NTP.
As shown in Figure 6C (right panel), a helicase activity
was observed with the La autoantigen but could not be
detected in the Stau1
55D2-his6 preparation. These results
show that Stau1
55D2-his6 does not have helicase activity
in vitro. These results suggest that Stau1 likely acts on
the translational machinery to enhance structured RNA
translation.
The Stau1
55 mutants that are unable to increase
translation cofractionate with polysomes
Since Stau1
55 associates with ribosomes (19,26), it might
facilitate the positioning of the TAR-bearing transcript on
the ribosomes and/or directly modulate ribosome activity.
Therefore, one reason that Stau1
55 mutants failed to increase
translation (Figure 5D) might be because the introduced muta-
tions impaired their capacity to associate with ribosomes.
Figure 5. TheStau1
55RNA-bindingactivityisrequiredforTAR-bearingRNAtranslationalregulation.(A)Schematicrepresentationofwild-typeStau1
55-HA3and
oftwomutantswithdisruptedRNA-bindingactivity.SymbolsaredescribedinthelegendofFigure1.(B)HEK293Tcellsweretransfectedwithplasmidscodingfor
eitherStau1
55-HA3,Stau1
55F-HA3 orStau1
55KK-HA3.Taggedproteinswereimmunoprecipitatedwithananti-HAantibodyandresultingproteinswereanalysedby
SDS–PAGE.Western blotting(upperpanel)using anti-Stau1antibodyand Northwestern blotting(lowerpanel) using[
32P]labelledTARRNA.Arrowsindicatethe
position of Stau1-HA3. *Non-specific IgG bands. (C) HEK293T cells were transfected with plasmids coding for either Stau1
55-HA3, Stau1
55F-HA3 or Stau1
55KK-
HA3 and proteinswere analysedby SDS–PAGEand westernblottingusinganti-Stau1and anti-tubulinantibodies.Similaramountsofproteins are expressedbythe
three plasmids. (D) HEK293T cells were co-transfected with plasmids expressing either Rluc or TAR-Rluc transcripts and different concentrations of plasmids
codingforeither Stau1
55F-HA3 (leftpanel) orStau1
55KK-HA3 (rightpanel).Resultingluciferase activitywasquantified asdescribed in Figure2B.Inthe absenceof
Stau1
55-HA3, a 2-fold repression of translation of the TAR-Rluc RNA was observed as compared with translation of Rluc RNA. To facilitate comparison, fold
inductionoftheluciferaseactivityintheabsenceofStau1
55-HA3wasdefinedas1.Differencesarenotstatisticallysignificant(n ¼ 3).Blackbars,TAR-RlucRNA;
hatched bars, Rluc RNA.
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plasmids coding for Stau1
55-HA3 or Stau1
55-HA3 mutants and
treated with cycloheximide. Cell extracts were centrifuged on
a continuous 10–40% sucrose density gradient to separate free
ribosomes from polysomes. As shown in Figure 7A, Stau1
55-
HA3, Stau1
55F-HA3 and Stau1
55KK-HA3 were mainly found in
fractions containing polysomes, showing that the mutations
did not impair the capacity of the mutants to cosediment with
ribosomes.
We next determined whether ribosomes that are associated
with the Stau1
55 mutants have impaired translational capabil-
ity, e.g. by forming non-translating polysomes. To explore this
possibility, centrifugation experiments were repeated follow-
ing treatment with sodium azide, a non-speciﬁc inhibitor of
translation initiation (51). In this assay, mRNA-bound ribo-
somes are able to complete translation of the bound RNA but
free ribosomes are unable to initiate translation. As a result,
large polysomes disappear and the amounts of free ribosomes
or ribosomal subunits increase. Following sodium azide
treatment, large amounts of both Stau1
55-HA3 and Stau1
55-
HA3 mutants were shifted from fractions containing heavy
polysomes to fractions of monosomes and small polysomes
(Figure 7B). Quantitation of the amounts of Stau1
55-HA3,
Stau1
55F-HA3 and Stau1
55KK-HA3 in the presence or in the
absence of sodium azide revealed a reduction of 54.0, 54.4 and
58.8%, respectively, in the association with heavy polysomes.
These results demonstrate that the mutations did not impair the
capacity of the mutated Stau1
55 proteins to bind actively trans-
lating polysomes. Although we do not exclude the possibility
that the mutations prevent association with essential transla-
tion factors, these results suggest that Stau1 acts as a carrier to
facilitate transport/positioning of target RNAs on translating
ribosomes.
Stau1
55 overexpression causes ashift of TAR-containing
transcripts to dense polysomes
In order to determine how Stau1 was inﬂuencing the TAR-
Rluc RNA proﬁle in polysomes, cells were transfected with
plasmids expressing TAR-Rluc or Rluc, in the absence or in
the presence of plasmids coding for Stau1
55-HA3. In the
absence of Stau1
55-HA3, the TAR-Rluc RNA was mostly
  
Figure6.Stau1
55mediatedtranslationalup-regulationdoesnotinvolvedRNAmodification.(A)TAR-CATRNAwasincubatedinRRLinthepresenceof400nMof
bacterially expressed and purified Stau1
55D2-his6 or BSA for increasing periods of time. TAR-CAT RNA was then reverse transcribed and PCR amplified for 14
cyclestostayinthenon-saturatedpartoftheamplificationcurve.ResultingDNAwasresolvedonagarosegel.Ascontrol,thesameexperimentwasperformedinthe
absence of reverse transcriptase (right panel). (B) HEK293T cells were co-transfected with plasmids expressing either Rluc or TAR-Rluc transcripts and different
concentrationsofaplasmidcodingforStau1
55-HA3.Twenty-fourhourspost-transfection,RNAwasisolated,reversetranscribedandPCRamplified.ResultingDNA
wasresolvedonagarosegel. Ascontrol,thesame experiment wasperformedin theabsenceofreversetranscriptase( RT).RNA codingforGAPDHwasRT–PCR
andusedtonormalizetheresults.(C)Bacteriallyexpressedandcolumn-purifiedStau1
55D2-his6(Stau)andLa-his6(La)(leftpanel)wereincubatedwith[
32P]labelled
double-strandedRNAinthepresenceofdifferentcombinationsofribonucleotides(rightpanel).RNAwasresolvedonagarosegelandrevealedbyautoradiography.
While La-his6 displayed an helicase activity, Stau1
55D2-his6 was inactive in this assay.
4806 Nucleic Acids Research, 2005, Vol. 33, No. 15found in fractions corresponding to 80S ribosomes and light
polysomes that contain few ribosomes (Figure 8A). However,
in the presence of Stau1
55-HA3, the TAR-Rluc RNA was
shifted to heavy polysome fractions. In contrast, the Rluc
RNA was found in heavy polysome fractions, in both the
presence and absence of co-transfected Stau1
55-HA3
(Figure 8B). Interestingly, in the presence of Stau1
55-HA3,
the percentage of TAR-Rluc RNA inheavy polysome fractions
was roughly the same as that of Rluc RNA in the presence or in
the absence of Stau1
55-HA3, consistent with the synthesis of
similar amounts of Rluc protein (see above). These results
suggest that Stau1
55 increases the probability to initiate
TAR-Rluc RNA translation, thus increasing the number of
attached ribosomes to form heavier polysomes and enhancing
the global rate of translation of this transcript.
Stau1 increases translation of structure-repressed
transcripts when tethered at the 50 end
To establish a correlation between Stau1 binding to the 50 end
of transcripts and its ability to enhance translation, we substi-
tuted the TAR-RNA structure with other structured RNA
sequences. The SBS that was recently identiﬁed by us (52)
or two copies of the MS2 binding site (MS2bs) were fused to
the 50 end of the Rluc transcript (Figure 9A). First, HEK293T
cells were co-transfected with a ﬁxed amount of either Rluc or
SBS-Rluc cDNA and increasing amounts of cDNA coding for
Stau1
55-HA3. As shown in Figure 9B, Stau1
55-HA3 stimulated
translation of SBS-Rluc RNA about 5-fold as compared with
SBS-Rluc RNA translation in the absence of transfected
Stau1
55-HA3. This effect was at the translational level because
the SBS-Rluc transcript did not vary with Stau1
55-HA3 expres-
sion (Figure 9C). Similarly, cells were co-transfected with a
ﬁxed amount of the MS2bs-Rluc plasmid and increasing con-
centrations of MS2-Stau1
55-HA3 or MS2-HA3 as a negative
control. MS2-Stau1
55-HA3 increased translation about 3-fold
as compared with MS2-HA3 (Figure 9D) showing that the
effect is speciﬁc to Staufen1. Importantly, co-transfection of
Stau1
55-HA3 (instead of MS2-Stau1
55-HA3) did not increase
translation of the MS2-Rluc transcript (Figure 9D) showing
that Stau1
55 recruitment to the structured 50 end of RNA is
critical for increased translation of these RNAs.
DISCUSSION
In this paper, we show that Stau1
55 increases translation of
mRNAs when bound to their 50 end. Consequently, Stau1
55 is
not a general regulator of translation but rather acts on speciﬁc
mRNA targets, through direct binding to their 50 end. Indeed,
our data establish a signiﬁcant correlation between the binding
of Stau1
55 to the 50 end of a transcript and its ability to enhance
translation. Interestingly, a maximal increase of expression
was observed when a natural SBS (52) was fused at the
50 end of Rluc. The Stau1
55-mediated up-regulation of trans-
lation is of the same order of magnitude as those reported
Figure 7. Stau1
55 mutants unable to modulate TAR-Rluc translation are nevertheless associated with ribosomes. HEK293T cells were transfected with plasmids
coding for Stau1
55-HA3, Stau1
55F-HA3 or Stau1
55KK-HA3. Cells were treated with either cyclohexemide (A) or sodium azide (B) for 20 and 30 min, respectively,
beforebeinglysed.Cellextractswereseparatedonto10–40%sucrosegradientsandproteinsineachfractionwereanalysedbySDS–PAGEandwesternblottingusing
anti-HA and anti-ribosomal protein L7 antibodies. Positions of 40S, 60S ribosomal subunits, 80S ribosomes and polysomes are indicated as revealed by the OD254
scan of the gradients.
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exon-junction complex on MS2-containing RNAs (53). In
both the RRL assays in vitro and following transfection of
cultured cells, the ratio of recombinant to endogenous Stau1
55
proteins associated with ribosomes and necessary to observe
an effect on translation of TAR-bearing mRNAs is quite simi-
lar. In both cases, the amount of recombinant Stau1
55 that is
required for optimal stimulation of translation is about one-
ﬁfth the level of the endogenous Stau1
55 (Figures 1D and 2B).
Therefore, it suggests that within a cell a slight variation in the
expression of endogenous Stau1
55 may regulate the translation
ofStau1
55-bound mRNAs. Physiologically relevanttranscripts
harbouring structured 50 end are likely to be translationally
repressed in the cells due to the translational block imposed by
these structures (15,16). Therefore, their regulated interaction
with Stau1
55 would allow a concerted expression of a speciﬁc
set ofStau1
55-boundtranscriptsinresponse tocell’sneeds (see
below).
Other RNA-binding proteins have been shown to bind the
TAR RNA structure and affect translation of TAR-bearing
transcripts. Since both TRBP (34,41) and La antoantigen
(42) were shown to increase translation of TAR-bearing
RNA, as does Stau1
55, an indirect mechanism of translational
repression involving competition between these proteins for
the TAR RNA structure can be excluded. Inhibition of their
function through competition should rather repress translation
of TAR-bearing transcripts. In contrast, PKR activation
through RNA binding was shown to repress translation
Figure 8. InthepresenceofStau1
55-HA3,TAR-Rluctranscriptsareshiftedtofractionscontainingheavypolysomes.HEK293Tcellsweretransfectedwithplasmids
expressingeitherTAR-Rluc(A)orRluc(B)transcripts(toppanels)orco-transfectedwiththesameplasmidsandplasmidscodingforStau1
55-HA3(bottompanels).
Twenty-fourhourspost-transfection,cellextractswerecentrifugedonto15–45%sucrosegradientsandthepositionofribosomalsubunits,ribosomesandpolysomes
determinedbyOD254(datanotshown).Positionofpolysomesisindicated.RNAwasisolatedfromeachfractionandanalysedbyslot-blottingandhybridizationusing
[
32P]labelledluciferasecDNA.Ascontrol,theproberecognizedasinglebandonanorthernblotmadewithRNAisolatedfromRluc-transfectedHEK293Tcells(data
notshown).ThepercentageofRNAineachfractioninrelationtotheamountoftotalRNAisplottedabovethehybridizationblots.ThepercentageofRNAfoundin
heavypolysomesisindicatedbelow theblots.Similarresultswereobtainedthreetimes.Theincreaseinthe amountsofTAR-Rluc transcriptsassociatedwithheavy
polysomesinthepresenceofStau1
55-HA3isstatisticallysignificant(P < 0.05),whereasthesmalldecreaseintheamountsofRluctranscriptsassociatedwithheavy
polysomes in the presence of Stau1
55-HA3 is not statistically significant.
4808 Nucleic Acids Research, 2005, Vol. 33, No. 15(15,40). Therefore, binding of Stau1
55 to the TAR RNA struc-
ture may mask the PKR binding site, preventing PKR activa-
tion and indirectly enhancing general translation. However,
even if the Stau1
55-binding site on TAR partly overlaps that
of PKR (33), we show that the Stau1
55-mediated increase in
translation of TAR-bearing RNA is independent of PKR both
in vitro and in cell cultures (Figure 3). Nevertheless, a mecha-
nism of competition between Stau1
55 and PKR for binding
RNAs or sequestration of PKR through direct binding to
Stau1
55 may explain the slight increase in the translation of
CAT transcripts in vitro. This small increase was not seen in
cultured cells, however.
Stau1
55-mediatedup-regulationofproteinexpressionoccurs
at the translational level. Steady-state analyses of RNAs show
thatStau1
55doesnotprotectTARtranscriptsfromdegradation
and does not increase transcription. Moreover, Stau1
55 does
not unwind dsRNA through helicase activity at least in vitro.
Therefore, although Stau1
55 RNA-binding activity is required,
Stau1
55 has no observable effect on RNA metabolism. It was
suggested that the secondary structure of TAR affects trans-
lation by preventing the accessibility of the cap structure (29).
In this context, Stau1
55 may favour access of this highly struc-
tured RNA to the ribosomal and/or translational machinery.
Binding of Stau1
55 to TAR-bearing transcripts may (i) facili-
tate transport and positioning of the transcripts on the ribo-
somes, (ii) destabilize the TAR RNA structure, allowing
binding of eIF4E and/or (iii) facilitate interaction between
co-factors, the TAR structure and the ribosomes. Therefore,
our working hypothesis is that Stau1
55 ﬁrst binds selected
RNAs and facilitates their transport and positioning on the
ribosomes through its capacity to associate with ribosomes.
Then, Stau1
55- and/or Stau1
55-associated proteins may help to
destabilize the 50 end structure leading to better interaction
with translation initiation factors, such as eIF4E and/or the
translational machinery. This effect would allow more
ribosomes to be bound to the transcript (Figure 8) and
Figure 9. BindingofStau1
55tothe50 endincreasestranslationofstructure-repressedtranscripts.(A)Schematicrepresentationof50-structure-repressedtranscripts.
RNAscodingfortheRlucreporterproteinareshownwithonecopyoftheSBSortwocopiesoftheMS2-bindingsite(MS2bs)atthe50 end.(B)HEK293Tcellswere
co-transfected with plasmids expressingeither Rluc or SBS-Rluc transcripts and different concentrationsof a plasmid coding for Stau1
55-HA3. Resultingluciferase
activity was quantified 24 h post-transfection. In the absence of Stau1
55-HA3, a 100-fold repression of translation of the SBS-Rluc RNA was observed as compared
with translation of Rluc RNA. Results are expressed as luciferase activity versus concentration of the Stau1
55-HA3 coding plasmid. To facilitate comparison, the
luciferaseactivityintheabsenceofStau1
55-HA3wasdefinedas1.P < 0.01,n ¼ 3.Blackbars,SBS-RlucRNA;hatchedbars,RlucRNA.(C)HEK293Tcellswere
co-transfected with plasmids expressing the SBS-Rluc transcript and different concentrations of a plasmid coding for Stau1
55-HA3. Twenty-four hours post-
transfection,RNAwasisolated,reversetranscribedandPCRamplified.ResultingDNAwasresolvedonagarosegel.Ascontrol,thesameexperimentwasperformed
intheabsenceofreversetranscriptase( RT).RNAcodingforGAPDHwasRT–PCRandusedtonormalizetheresults.(D)HEK293Tcellswereco-transfectedwith
plasmids expressing the MS2bs-Rluc transcript and different concentrations of plasmids coding for either MS2-Stau1
55-HA3, MS2-HA or Stau1
55-HA3. Resulting
luciferase activity was quantified 24 h post-transfection. In the absence of MS2-Stau1
55-HA3, a 100-fold repression of translation of the MS2bs-Rluc RNA was
observed as compared with translation of Rluc RNA. To facilitate comparison, the luciferase activity in the absence of expressor plasmids was defined as 1, n ¼ 3.
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factors, helicases are known to inﬂuence translation of
mRNAs containing secondary structures at their 50 ends, help-
ing to disrupt the secondary structures and to translocate the
RNA within the polysomes (42,54–57). Moreover, they are
frequently associated with RNA-binding proteins (58,59). At
least two RNA helicases, RHA and La autoantigen, were
shown to bind the TAR RNA element and inﬂuence TAR-
mediated transcription and translation, respectively (35,42).
Interestingly, RHA was identiﬁed in two independent pro-
teomic analyses of Stau1-containing complexes (27,28).
While it would also be interesting to test if direct binding
of Stau1
55 to ribosomes is required for its function on trans-
lation, all of the Stau1 mutations tested to date that prevent
Stau1
55-ribosome association also impair Stau1
55 RNA-
binding activity (26).
Alternatively, Stau1
55 through its observed association with
the 60S ribosomal subunit (26) may directly modify ribosomal
activity, favouring the joining of the 60S ribosomal subunit to
the translation initiation complex and/or inﬂuencing transla-
tional elongation. Stau1
55 may also interact with chaperones
that facilitate proper folding of nascent proteins thus increas-
ing the translation elongation rate or it may interfere with the
association of trans-acting protein repressors to 30-o r5 0-UTR
of RNA. The former hypothesis is not likely since the same
protein is translated from TAR-Rluc and Rluc transcripts. In
Drosophila, Staufen protein was shown to be essential for the
translational de-repression of oskar mRNA once properly
localized in the oocyte (10,18). Translational repression of
oskar mRNA depends on functional association of proteins
that bind both its 30- and 50-UTR (10,60–62) and on protein
involved in the stabilization of the nascent protein (63). Inter-
estingly, the 50-UTR of oskar mRNA contains an RNA
sequence/element that is required for its translational
de-repression when localized at the posterior pole (60).
What is the biological relevance of Staufen in translational
regulation? Proteomic (25,27,28,64) and cell biology
(21–24,65) experiments clearly establish that Stau1 is a com-
ponent of the RNA transport machinery in several cell types.
In neurons, Stau1 granules also contain RNAs and move in
dendrites on microtubules (23,24), suggesting that Stau1 func-
tion might be linked to mRNA transport. This conclusion is
supportedbytheobservationthatthedown-regulationofStau1
bysiRNA reduces the amounts of RNA in dendrites of neurons
(25). While the exact role of Staufen has yet to be deﬁned, it is
clear that Stau1
55 plays multiple role(s) in cells in addition to
its role in RNA transport. Stau1
55 is associated with telom-
erase and/or telomeric RNA in the nucleolus (66,67), suggest-
ing that it has nuclear function. In the cytoplasm, Stau1
55
regulatesRNAstability(52)anditcanalsoregulate translation
of a subpopulation of transcripts (this paper). These functions
may allbecomplementarytoitsputativeroleinRNA transport
such that in both RNA transport granules and stress granules,
translation is known to be repressed (68–70) and it must
resume once the transcripts are localized or when physiolo-
gical conditions are returned to normal. Stau1
55 is likely
associated to RNA during transport and to translation
following localization as demonstrated for Staufen in
Drosophila (10). Since the 50-SBS-bearing transcripts are
translationally repressed, a 5-fold increase in their translation
following Stau1
55 binding is functionally signiﬁcant. Several
Stau1
55-bound transcriptscode forproteinsinvolved inthecell
metabolism and/or cell growth (52) making critical the regu-
lation of their translation. The site of Stau1
55 binding on the
RNA may determine the nature of the induced process. When
bound downstream of a natural termination codon, Stau1
55
elicits RNA degradation (52) whereas its binding to the 50-
UTR of a transcript enhances translation but not RNA
degradation. Similar observations were reported for the pro-
teins of the exon-junction complex that can either induce non-
sense mediated RNA decay or enhance translation (53).
Stau1
55 post-translational modiﬁcations and/or its association
with different co-factors may regulate these processes, in
responsetothecell’sneeds,forinstance.These resultsindicate
that Stau1 is a multifunctional protein. Analyses of Stau1
55-
endogenous RNA ligands will contribute to elucidate these
mechanisms.
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